Showing results (71-80 of 159) with videos related to
Sort By:
Pageof 16
Expert Opinion on Biological Therapy|December 3, 2015
Talimogene laherparepvec in the treatment of melanomaElizabeth S Appleton, Samantha Turnbull, Christy Ralph, et al.Iscience|January 25, 2024
DNA-PKcs is required for cGAS/STING-dependent viral DNA sensing in human cellsDayana B Hristova, Marisa Oliveira, Emma Wagner, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 5, 2009
Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidityPaul Hatfield, Mohan Hingorani, Ganesh Radhakrishna, et al.FEBS Letters|March 6, 2007
Expression of the CUB domain containing protein 1 (CDCP1) gene in colorectal tumour cellsSara E Perry, Philip Robinson, Alan Melcher, et al.Molecular Therapy. Nucleic Acids|May 23, 2013
CARbodies: Human Antibodies Against Cell Surface Tumor Antigens Selected From Repertoires Displayed on T Cell Chimeric Antigen ReceptorsVanesa Alonso-Camino, David Sánchez-Martín, Marta Compte, et al.Cancer Gene Therapy|May 4, 2018
Synergistic antitumour effects of rapamycin and oncolytic reovirusCharles Comins, Guy Richard Simpson, William Rogers, et al.Human Gene Therapy|August 7, 2002
Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery?Kevin Harrington, Luis Alvarez-Vallina, Marka Crittenden, et al.Frontiers in Oncology|July 27, 2016
Sickle Cells Abolish Melanoma Tumorigenesis in Hemoglobin SS Knockin Mice and Augment the Tumoricidal Effect of Oncolytic Virus In VivoChiang Wang Sun, Candice Willmon, Li-Chen Wu, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 5, 2006
Killing of normal melanocytes, combined with heat shock protein 70 and CD40L expression, cures large established melanomasLuis Sanchez-Perez, Timothy Kottke, Gregory A Daniels, et al.Blood|February 26, 2025
Synergistic antitumor effect of combined EZH2 and DOT1L inhibition in B-cell lymphomaVan Thuy Mai Nguyen, Hiroe Namba, Hayley Porter, et al.Pageof 16